polyethylene glycol 3350 420000 MG / potassium chloride 1480 MG / sodium bicarbonate 5720 MG / sodium chloride 11200 MG [GaviLyte-N]
RxNorm concept 1719699, branded drug component (sbdc).
- RxCUI
- 1719699
- Term type
- Branded drug component (SBDC)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1719699 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- polyethylene glycol 3350 420000 MG / potassium chloride 1480 MG / sodium bicarbonate 5720 MG / sodium chloride 11200 MG Powder for Oral Solution [GaviLyte-N] (SBD, constitutes)
- GaviLyte-N (BN, has ingredient)
- polyethylene glycol 3350 420000 MG (SCDC, tradename of)
- potassium chloride 1480 MG (SCDC, tradename of)
- sodium bicarbonate 5720 MG (SCDC, tradename of)
- sodium chloride 11200 MG (SCDC, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1719699 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1719699 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1719699. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.